oSober^i92o.'^°'' }  Meeting  of  American  Chemical  Society.  745 
ceutical  Chemistry  to  Division  of  Chemistry  of  Medicinal  Products ; 
changing  the  name  of  the  Carney's  Point  Section  to  South  Jersey 
Section;  going  on  record  as  favoring  the  purchase  of  Liberty  Bonds 
for  investment  purposes;  fixing  the  date  of  the  spring  meeting  at 
Rochester,  N.  Y.,  for  the  week  of  April  25th;  selecting  Pittsburgh 
as  the  fall  meeting  city  unless  arrangements  can  be  made  for  a 
joint  meeting  of  the  Canadian  and  British  Societies  of  Chemical 
Industry  with  the  American  Chemical  Society  at  New  York  either 
preceding  or  following  the  Chemical  Exposition  in  New  York  next 
September;  cautioning  local  sections  of  the  Society  against  affilia- 
tions with  local  engineering  organizations  which  may  involve  the 
parent  body  in  matters  of  public  policy  favored  by  engineers  but 
not  of  interest  to  chemists;  re-election  of  the  present  editors  of  the 
three  journals  of  the  Society  to  serve  for  one  year;  authorizing  the 
appointment  of  a  committee  of  thirteen  to  cooperate  with  the  Chemi- 
cal Warfare  Service  along  lines  of  research,  development,  produc- 
tion and  physiological  questions;  re-endorsing  the  position  taken  at 
the  last  meeting  in  favor  of  the  dyestuffs  protection  bill  still  before 
Congress;  increasing  the  annual  dues  from  $10  to  $15  with  the 
proviso  that  undergraduate  and  graduate  students  may  secure  such 
membership  for  $10  per  annum. 
Meetings  of  the  various  divisions  of  the  Society  were  held  at  the 
University  of  Chicago,  Wednesday  and  Thursday,  September  8  and  9. 
The  program  of  the  Division  of  Chemistry  of  Medicinal  Products 
included  papers  on  the  newer  anti-spasmodics  of  the  benzyl  benzoate 
type.  Reports  were  made  by  various  investigators  on  benzyl 
succinate,  benzyl  esters  of  salicylic  acid,  and  benzyl  esters  of  the 
higher  fatty  acids.  There  seemed  to  be  an  undercurrent  of  opinion 
that  benzyl  benzoate  could  be  improved  upon  and  it  is  evident  that 
many  manufacturers  are  engaged  in  research  work  along  this  line. 
An  entire  afternoon  was  devoted  by  this  section  to  a  discussion 
of  methods  of  cooperation  with  the  National  Research  Council. 
Dr.  Wilder  D.  Bancroft,  of  the  Council,  advocated  the  framing  of  a 
complete  program  of  research  along  medicinal  chemical  lines, 
after  which  the  aid  of  the  Council  could  be  counted  upon  in  carrying 
out  the  work  outlined.  Dr.  C.  H.  Herty  expressed  the  hope  that 
an  institute  for  research,  along  the  lines  of  developing  synthetic 
medicinal  compounds,  be  organized  in  the  near  future  and  mentioned 
the  possibility  of  securing  financial  aid  for  this  purpose  through  the 
Chemical  Foundation.    After  considerable  discussion  on  this  subject 
